DVA
DaVita Inc.Stock · HealthcareS&P 500 Equal Weight 0.2% · S&P 500 0.01% · Russell 1000 0.01% · Russell 3000 0.010% · US Stock Market 0.010%$183.86+0.42%
as of market close, Sep 18, 2026
☾ AH — —
DVA — DaVita Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
Volume
60.080.0100.0120.0140.0160.0180.0200.0220.0020.0M$183.86—20162019202120242026
2026-09-18
Price$183.86
MA20$191.54
MA50$155.25
Vol5.5M
Key stats
Price data
- Price
- $183.86
- Change YTD
- +61.83%
- Next earnings
- Nov 4, 2026
- Market cap
- 11.7B
- Enterprise value
- 24.9B
- Shares outstanding
- 63.8M
- 52W low
- $101.00
- 52W high
- $247.49
- From 52W high
- -25.71%
- From 52W low
- +82.04%
- 52W range
- 57%
- Beta
- 0.86
Volume
- Rel volume
- 2.83×
- 30D volume
- 741.4K
- 30D $ vol
- 134.4M
Fundamentals
- Sales (ttm)
- 14B
- Sales/share
- $219.59
- EPS (ttm)
- $12.11
- FCF (ttm)
- 1.6B
- FCF/share
- $25.23
- Book value/share
- -$11.99
- Net margin
- 6.05%
- ROA
- 4.79%
- Current ratio
- 1.47
Growth (CAGR, ttm) · 10Y
- Sales
- +6.45%+6.07%+3.91%+2.87%
- Net income
- +1.34%+21.91%-0.38%+8.92%
- FCF
- +24.98%+5.87%+7.45%+2.28%
- Shares
- -10.78%-11.26%-9.45%-11.10%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +18.84%+33.91%+10.03%+21.70%
- Sales/share
- +19.31%+19.53%+14.75%+15.69%
- FCF/share
- +40.08%+19.30%+18.66%+15.05%
- Price
- +41.21%+22.60%+8.63%+11.05%
- Total return
- +41.21%+22.60%+8.63%+11.05%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 15.2×
- P/OI (ttm)
- 5.5×
- Fwd P/E
- 11.2×
- P/S (ttm)
- 0.8×
- P/B (mrq)
- -15.3×
- P/FCF (ttm)
- 7.3×
- EV/EBITDA (fy)
- 9.0×
- EV/Sales (ttm)
- 1.8×
- FCF yield (ttm)
- 13.72%
- Buyback yield (realized, 1y)
- 10.78%
- Shareholder yield (realized, 1y)
- 10.78%
- Buyback yield (cash, ttm)
- 7.61%
- Shareholder yield (cash, ttm)
- 7.61%
Vs own 10Y history
- P/E
- 45th
- P/OI
- 31st
- P/S
- 41st
- P/B
- 98th
- P/FCF
- 27th
Bar = where today’s multiple sits in DVA’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-09-18
1D
+0.42%
5D
+1.27%
1M
+3.34%
3M
-11.57%
YTD
+61.83%
1Y
+41.18%
5Y
+51.26%
Financial statements
Open full DVA financials →Loading financial statements…
Related Healthcare
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | -5.94% | +0.04% |
| JNJ | Johnson & Johnson | -0.41% | -0.09% |
| ABBV | AbbVie Inc. | +1.95% | -0.02% |
| MRK | Merck & Co. Inc. | +8.66% | -0.19% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | -4.32% | +0.45% |
| TMO | Thermo Fisher Scientific Inc. | +10.60% | -1.04% |
| AMGN | Amgen Inc. | -9.32% | +1.55% |
| GILD | Gilead Sciences Inc. | +4.65% | -0.52% |
DaVita Inc. (DVA) trades at $183.86 with a live price and an interactive chart covering 30+ years of daily price history, plus key valuation metrics. ChartRow also publishes DVA’s financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full DVA financial statements →
